Dr. John Cush

@RheumNow

Know-it-Now. Info on RA, Stills disease, Lupus, Gout, Pregnancy, Spondylitis, Psoriasis, Drug Safety, Rheumatology Research, Medical Education & Drug Evaluation

Dallas, TX
Vrijeme pridruživanja: travanj 2011.

Tweetovi

Blokirali ste korisnika/cu @RheumNow

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RheumNow

  1. prije 11 sati

    QD Clinic - Part 3 of my discussion of 2020 EULAR recommendations for RA treatment - this one addresses the use of MTX, GC & T2T. Watch on Youtube or Listen to the podcast 01:15 PM (CST)

    Poništi
  2. prije 18 sati

    QD Clinic - Part 2 of my discussion of 2020 EULAR recommendations for RA treatment Watch on Youtube or or Listen to the podcast

    Poništi
  3. prije 19 sati

    Claims cohort study looked at serious infection in RA pts Rx w/ tofacitinib vs 7 biologics. Overall risk was 3.12/100PYs. Signif higher SIE in TOFA vs ETN (aHR 1·41), lower vs INFLX (0.81), similar to ABA, GOL, TCZ, ADA. TOFA 2X higher risk of Shingles

    Poništi
  4. prije 22 sata

    Tacrolimus as an option in RA? Metanalysis of 5 studies shows odds of achieving ACR20 was 1.71 (95% CI 1.20-2.42) for 1-2 mg/day and 2.30 (1.79-2.96) for 3 mg/day. Odds of creatinine elevation was 1.95 for 1-2 mg/day and 3.81 for 3mg/day. 

    Poništi
  5. prije 22 sata

    Wear a face mask to prevent others from catching whatever infection you have. It doesnt work to prevent you from getting the flu, Corona or chikungunya from others

    Poništi
  6. prije 24 sata

    "Kites rise highest against the wind - not with it." - Winston Churchill

    Poništi
  7. 4. velj

    QD Video - I discuss 2020 EULAR recommendations for RA treatment - Part I Watch on Youtube or or Listen to the podcast

    Poništi
  8. 4. velj

    Head drop - as a Sx of myopathy? 107 pts reviewed; 53% w/ specific Dx: Inflammatory myositis(n = 16), myopathy w/ rimmed vacuoles (10), radiation(8), nemaline ( 7), myofibrillar (4), facioscapulohumeral ( 3), 2 ea w/ incl. body,mitochondrial, PSS

    Poništi
  9. 4. velj

    "Mistakes are the portals of discovery." - James Joyce

    Poništi
  10. 3. velj

    Danish Registry study of 12,185 Chronic Urticaria patients shows an overrepresentation mastocytosis and anaphylaxis, as well as atopic dermatitis, rheumatoid arthritis, SLE, thyroiditis and vitiligo

    Poništi
  11. 3. velj

    Study of 368 SLE pts (1998 to 2012) found a high prevalence of epilepsy. Survey suggested epilepsy in 42% but evaluation found 36 (11.5%) w/ Sx, 83% w/ focal onset. Other manifestations of NPSLE in 50%, w/ 2-3 fold higher risk of CVA, psychosis & APS

    Poništi
  12. 3. velj

    MRA vs FDG-PET in newly Dx GCA and Takayasus shows a differences in Sxs & imaging. Carotidynia & arm claudication more common in TAK with evidence of vascular inflammation (PET). GCA lesions by MRA showed more damage than inflammation

    Poništi
  13. 3. velj

    "We can't solve problems by using the same kind of thinking we used when we created them" -Albert Einstein

    Poništi
  14. 3. velj

    The RheumNow Podcast is up! - Watch it here or listen to the podcast in the car, when you run or while folding clothes

    Poništi
  15. 2. velj

    Dr. Kermani - in GCA PET may be best at capturing Activity, while MRA may best define Extent of disease

    Poništi
  16. 1. velj

    QD Clinic - videos and podcast on patient care issues - this week: isolated inflammatory hip arthritis; monitoring vasculitis; mistakes in pain management; & when to use anakinra. Watch videos on or listen by podcast

    Poništi
  17. 31. sij

    Swedish nationwide registers studied births in IIM/myositis pts betw 1973 - 2016 & found increased risk of caesarean section (aRR = 1.98), preterm birth ( 3.35) and low birth weight ( 5.69) AND incr risk of C-sections 1-3 yrs prior to the Dx of IIM

    Poništi
  18. 31. sij

    "A lie gets halfway around the world before the truth has a chance to get its pants on". Winston Churchill

    Poništi
  19. 30. sij

    CORRONA study of ~800 RA patients shows that high and low comorbidity scores and BMI status (obese BMI ≥ 30; n = 356 vs nonobese BMI < 30; n = 449) did not impair or alter the effectiveness of tocilizumab.

    Poništi
  20. 30. sij

    CORRONA study of ~800 RA patients shows that high and low comorbidity scores and BMI status (obese BMI ≥ 30; n = 356 vs nonobese BMI < 30; n = 449) did not impair or alter the effectiveness of tocilizumab.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·